Ferr-Ease*trade;* delivers unique, patented dual-iron therapy
Ferralet® 90 is different. It now contains Ferr-Ease, a proprietary dual-iron formulation that simply has no substitute. Ferr-Ease delivers a unique blend of ferrous gluconate and carbonyl iron. Why? Because anemic patients are able to start absorbing iron almost as soon as it is delivered. In fact, studies show that the rate of iron absorption increases significantly in anemic patients almost immediately after administration.1 And since ferrous gluconate enters the body ready to be absorbed, it is there when the body needs it.
Carbonyl iron, on the other hand, allows gentle and prolonged solubilization and absorption.2† It is converted from the particulate to soluble ionized iron at a rate determined by the rate of gastric acid production.2 The result is oral iron therapy with excellent tolerability and safety.
In addition, the Ferralet 90 formulation offers many other unique advantages:
- 50 mg docusate sodium gently eases the constipation that can be experienced by patients sensitive to iron therapy
- Vanilla scent addresses the unpleasant taste and smell normally associated with iron therapy
- The formulation is free of lactose and gluten, alleviating common dietary concerns
- 120 mg Vitamin C to enhance iron absorption2
- 1 mg folic acid to bolster the development of red blood cells3
- 12 μg Vitamin B12 to support red blood cell generation4
Displays
NDC 0178-0083-90
Packaged in bottles of 90
Wholesaler Order Entry Numbers
| AmerisourceBergen | 5060280/629182 |
|---|---|
| Bellco | 284554 |
| Burlington Drug Co. | 730614 |
| Cardinal Health, Inc | 4077145 |
| Dakota Drug | |
| Dik Drug | |
| Frank W. Kerr | |
| H.D. Smith | 215-6024 |
| King Drug | |
| Kinray, Inc. | |
| Louisiana Wholesale | |
| McKesson Corp | 1808286 |
| McQueary Bros. Drug Co. | |
| Miami-Luken | |
| Morris & Dickson Co. | 848903 |
| NC Mutual Drug Co. | 665869 |
| Rochester | |
| Smith Drug Co. | |
| Valley Wholesales | 378927 |
| Value Drug Co. |
Important Safety Information
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
Warning
Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
Precautions
Administration of Drug- General: Take 2 hours after meals. Do not exceed recommended dose. Discontinue use if symptoms of intolerance appear. The type of anemia and underlying cause or causes should be determined before starting therapy with Ferralet® 90 tablets. Ensure Hgb, Hct, reticulocyte count are determined before starting therapy and periodically thereafter during prolonged treatment. Periodically review therapy to determine if it needs to be continued without change or if a dose change is indicated. This product contains FD&C Yellow No. 5 (tartrazine) which may cause allergic type reactions (including bronchial asthma) in certain susceptible persons. Although the overall incidence of FD&C Yellow No. 5 (tartrazine) sensitivity in the general population is low, it is frequently seen in patients who also have aspirin hypersensitivity.
- Folic Acid: Folic acid in doses above 0.1 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using these products since folic acid may mask the symptoms of pernicious anemia.
- Pediatric Use: Safety and effectiveness in pediatric patients have not been established.
- Geriatric Use: Dosing for elderly patients should be cautious. Due to the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy, dosing should start at the lower end of the dosing range.
This material is intended to provide basic information. Patients should discuss all medical advice, diagnosis, and treatment with their healthcare provider.
Please see full Prescribing Information
* US Patent no. 6,521,247 B1
† Based on animal studies.
- Lynch SR, Stoltzfus RJ. Iron and ascorbic Acid: proposed fortification levels and recommended iron compounds. J Nutr. 2003 Sep;133(9):2978S-84S.
- Folic acid [Internet]. WebMD; [updated 2007 Mar 5; accessed 2009 17 Dec]. Available from http://www.webmd.com/diet/folic-acid.
- Vitamin B12 [Internet]. MayoClinic.com; [cited 2009 17 Dec]. Available from http://www.mayoclinic.com/health/vitamin-B12/NS_patient-vitaminb12.
